Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION USP

Last updated on 2020-03-04 History
Report ID 97022
Drug Identification Number 02382636
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Common or Proper name HYDROmorphone Hydrochloride Injection USP HP 10
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 50mL GVL
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-22
Estimated end date 2020-04-30
Actual end date
Shortage status Actual shortage
Updated date 2020-03-04
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-03-04 French Compare
v6 2020-03-04 English Compare
v5 2019-11-13 French Compare
v4 2019-11-13 English Compare
v3 2019-10-23 English Compare
v2 2019-10-22 French Compare
v1 2019-10-22 English Compare